AAAAAA

   
Results: 1-10 |
Results: 10
Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents
Authors: Zaneveld, LJD Waller, DP Ahmad, N Quigg, J Kaminski, J Nikurs, A De Jonge, C
Citation: Ljd. Zaneveld et al., Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents, J ANDROLOGY, 22(3), 2001, pp. 481-490
Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate
Authors: Christensen, ND Reed, CA Culp, TD Hermonat, PL Howett, MK Anderson, RA Zaneveld, LJD
Citation: Nd. Christensen et al., Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate, ANTIM AG CH, 45(12), 2001, pp. 3427-3432
Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM)
Authors: Garg, S Anderson, RA Chany, CJ Waller, DP Diao, XH Vermani, K Zaneveld, LJD
Citation: S. Garg et al., Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM), CONTRACEPT, 64(1), 2001, pp. 67-75
Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases
Authors: Anderson, RA Feathergill, K Diao, XH Cooper, M Kirkpatrick, R Spear, P Waller, DP Chany, C Doncel, GF Herold, B Zaneveld, LJD
Citation: Ra. Anderson et al., Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases, J ANDROLOGY, 21(6), 2000, pp. 862-875
Poly(sodium 4-styrene sulfonate): An effective candidate topical antimicrobial for the prevention of sexually transmitted diseases
Authors: Herold, BC Bourne, N Marcellino, D Kirkpatrick, R Strauss, DM Zaneveld, LJD Waller, DP Anderson, RA Chany, CJ Barham, BJ Stanberry, LR Cooper, MD
Citation: Bc. Herold et al., Poly(sodium 4-styrene sulfonate): An effective candidate topical antimicrobial for the prevention of sexually transmitted diseases, J INFEC DIS, 181(2), 2000, pp. 770-773
A new vaginal antimicrobial contraceptive formulation: phase I clinical pilot studies
Authors: Ladipo, OA De Castro, MP Filho, LCCT Coutinho, E Waller, DP Cone, F Zaneveld, LJD
Citation: Oa. Ladipo et al., A new vaginal antimicrobial contraceptive formulation: phase I clinical pilot studies, CONTRACEPT, 62(2), 2000, pp. 91-97
Women's preferences for vaginal antimicrobial contraceptives I - Methodology
Authors: Hardy, E de Padua, KS Jimenez, AL Zaneveld, LJD
Citation: E. Hardy et al., Women's preferences for vaginal antimicrobial contraceptives I - Methodology, CONTRACEPT, 58(4), 1998, pp. 233-238
Women's preferences for vaginal antimicrobial contraceptives II - Preferred characteristics according to women's age and socioeconomic status
Authors: Hardy, E de Padua, KS Jimenez, AL Zaneveld, LJD
Citation: E. Hardy et al., Women's preferences for vaginal antimicrobial contraceptives II - Preferred characteristics according to women's age and socioeconomic status, CONTRACEPT, 58(4), 1998, pp. 239-244
Women's preferences for vaginal antimicrobial contraceptives III - Choice of a formulation, applicator, and packaging
Authors: Hardy, E Jimenez, AL de Padua, KS Zaneveld, LJD
Citation: E. Hardy et al., Women's preferences for vaginal antimicrobial contraceptives III - Choice of a formulation, applicator, and packaging, CONTRACEPT, 58(4), 1998, pp. 245-249
Women's preferences for vaginal antimicrobial contraceptives IV - Attributes of a formulation that would protect from STD/AIDS
Authors: Hardy, E de Padua, KS Osis, MJD Jimenez, AL Zaneveld, LJD
Citation: E. Hardy et al., Women's preferences for vaginal antimicrobial contraceptives IV - Attributes of a formulation that would protect from STD/AIDS, CONTRACEPT, 58(4), 1998, pp. 251-255
Risultati: 1-10 |